Acidosis: Clinical Trials

31 trials for Acidosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

13 completed, 4 recruiting, 4 terminated, 4 unknown. 31 Phase 3, 13 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 331Completed 13, Recruiting 4, Terminated 4, Unknown 4, Active not recruiting 3, Withdrawn 2, Enrolling by invitation 1
Phase 213Completed 5, Recruiting 3, Active not recruiting 2, Enrolling by invitation 1, Terminated 1, Withdrawn 1

Follow Acidosis: new trials by email Literature Review of Acidosis trials Research Report on Acidosis

Trials (filtered) newest first · largest first

All 31 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effects of Ketones on Brain Energetics and Alcohol Consumption in Alcohol Use Disorder
Kenetik, magnetic resonance imaging scan, Alcohol bar lab - Alcohol Use Disorder, Ketosis
Phase 2 / Phase 3RecruitingUniversity of Pennsylvania602026-12-012026-10-21
A Study to Evaluate the Efficacy and Safety of Veverimer for the Treatment of Metabolic Acidosis
Veverimer, Placebo - CKD, Metabolic Acidosis
Phase 3RecruitingRenibus Therapeutics, Inc.1502026-01-132026-10-23
Effects of Ketone Supplementation on Alcohol Withdrawal and Brain Metabolism in Alcohol Use Disorder
ketone supplement "D-beta-hydroxybutryric acid and R-1,3 butanediol" 12g of ketones,, magnetic resonance imaging session, Placebo beverage - Alcohol Use Disorder, Alcohol Withdrawal
Phase 2 / Phase 3RecruitingUniversity of Pennsylvania302025-08-012026-11-05
Effects of Ketone Supplement and Alcohol on Brain Metabolism
Kenetik, Alcohol beverage - Ketosis, Alcohol Drinking
Phase 2 / Phase 3Active not recruitingUniversity of Pennsylvania602025-05-132026-10-14
REAMBERIN® 1.5% in Rehydration Therapy of Diabetic Ketoacidosis
Reamberin, Placebo - Diabetic Ketoacidosis
Phase 2 / Phase 3RecruitingPOLYSAN Scientific & Technological Pharmaceutical Company3122025-05-012025-06-24
Bone in CKD Alkali Response (BICARb Pilot Trial)
Potassium Citrate Extended Release Oral Tablet, Placebo, Potassium Citrate and Citric Acid Oral Solution - Chronic Kidney Diseases, Bone Loss
Phase 2 / Phase 3TerminatedAlbert Einstein College of Medicine62024-08-152026-07-28
Prevention of Metabolic Acidosis in Preterm Neonates by Replacing Sodium Chloride With Sodium Acetate in Parenteral Nutrition
sodium acetate group will receive sodium acetate in the neonatal PN., sodium chloride group will receive sodium chloride in the neonatal PN. - Metabolic Acidosis, Neonatal Disease
Phase 3UnknownAga Khan University Hospital, Pakistan2002024-07-102024-08-09
Balanced Multi-Electrolyte Solution Versus Saline Trial for Diabetic KetoAcidosis
Plasma-Lyte 148, 0.9% sodium chloride - Diabetic Ketoacidosis
Phase 3CompletedThe George Institute5472024-03-142026-10-05
Effects of Ketone Supplementation on Acute Alcohol Withdrawal
Kenetik; Ketone Concentrate, Isocaloric dextrose placebo - Alcohol Use Disorder, Alcohol Withdrawal
Phase 2 / Phase 3Enrolling by invitationUniversity of Pennsylvania502024-03-112026-04-06
Effect of Nutritional Ketosis on Alcohol Metabolism
Ketone Supplement, Control Diet, Ketogenic diet - Ketoses, Metabolic, Ketogenic Dieting
Phase 2 / Phase 3Active not recruitingUniversity of Pennsylvania232024-02-292026-04-07
Extension Study in Primary Distal Renal Tubular Acidosis
ADV7103 - Acidosis, Renal Tubular
Phase 3WithdrawnAdvicenne Pharma2023-12-202026-02-09
SODium BICarbonate for Metabolic Acidosis in the ICU
Sodium bicarbonate, 5% Dextrose - Metabolic Acidosis, Shock
Phase 3Active not recruitingAustralian and New Zealand Intensive Care Research Centre5002023-04-262026-03-27
Study Evaluating Subjects With Distal Renal Tubular Acidosis
ADV7103, Placebo - Distal Renal Tubular Acidosis
Phase 3TerminatedAdvicenne Pharma32021-09-202026-06-03
Study of the Effect of SZC on Serum Potassium and Serum Bicarbonate in Patients With Hyperkalemia and Metabolic Acidosis Associated With Chronic Kidney Disease
Sodium zirconium cyclosilicate, Placebo - Hyperkalaemia, Metabolic Acidosis
Phase 3TerminatedAstraZeneca392021-03-222023-10-06
Exogenous Ketones for Acutely Decompensated HEart Failure
25g Ketone monoester without added salts, Placebo - Acute Heart Failure, Low Cardiac Output Syndrome
Phase 3UnknownInstitute for Clinical and Experimental Medicine242020-12-022021-01-06
Evaluation of Effect of TRC101 on Progression of Chronic Kidney Disease in Subjects With Metabolic Acidosis
TRC101, Placebo - Metabolic Acidosis, Chronic Kidney Disease
Phase 3TerminatedTricida, Inc.14802018-11-202022-10-14
Long-term Safety Extension to Study TRCA-301
TRC101, Placebo - Metabolic Acidosis
Phase 3CompletedTricida, Inc.1962017-12-202021-10-22
Evaluation of TRC101 in Subjects With Metabolic Acidosis Associated With Chronic Kidney Disease
TRC101, Placebo - Metabolic Acidosis
Phase 3CompletedTricida, Inc.2172017-09-262021-04-26
Comparative Analysis Between Ringer's Lactate vs Plasma Lyte-A as Cardiopulmonary Bypass Prime
Plasmalyte A, Ringer Lactate - Cardiopulmonary Bypass
Phase 3UnknownPost Graduate Institute of Medical Education and Research, Chandigarh602017-02-102017-02-03
Alcohol: Thiamine and or Magnesium 1
Magnesium Sulfate, Pabrinex - Alcohol Withdrawal, Lactic Acidosis
Phase 2 / Phase 3CompletedGlasgow Royal Infirmary1272016-12-162019-07-31

Showing 20 of 31. Sign in to see all of them.

Narrower conditions

Ketosis (8)  ·  Renal Insufficiency, Chronic (5)  ·  Acidosis, Lactic (3)  ·  Alcoholism (3)  ·  Diabetic Ketoacidosis (3)  ·  Kidney Diseases (3)  ·  Acidosis, Renal Tubular (2)  ·  Alcohol Drinking (2)  ·  Shock (2)  ·  Acidosis, Respiratory (1)  ·  Alcoholic Intoxication (1)  ·  Alzheimer Disease (1)  ·  Beriberi (1)  ·  Bone Diseases, Metabolic (1)

Broader conditions

Acid-Base Imbalance (31)  ·  Metabolic Diseases (31)  ·  Nutritional and Metabolic Diseases (31)  ·  Pathological Conditions, Signs and Symptoms (13)  ·  Female Urogenital Diseases (9)  ·  Female Urogenital Diseases and Pregnancy Complications (9)  ·  Male Urogenital Diseases (9)  ·  Urogenital Diseases (9)  ·  Urologic Diseases (9)  ·  Pathologic Processes (8)  ·  Disease Attributes (6)  ·  Kidney Diseases (6)  ·  Mental Disorders (6)  ·  Alcohol-Related Disorders (5)

Interventions

Sodium Bicarbonate (4)  ·  veverimer (4)  ·  Ethanol (3)  ·  Potassium Citrate (3)  ·  Sodium Chloride (2)  ·  Alcoholic Beverages (1)  ·  Alkalies (1)  ·  Bicarbonates (1)  ·  Citric Acid (1)  ·  Dichloroacetic Acid (1)  ·  Diet, Ketogenic (1)  ·  Dietary Supplements (1)  ·  Glucose (1)  ·  Ketones (1)  ·  Magnesium Sulfate (1)

Sponsors

University of Pennsylvania (5)  ·  Albert Einstein College of Medicine (3)  ·  Tricida, Inc. (3)  ·  Advicenne Pharma (2)  ·  Aga Khan University Hospital, Pakistan (1)  ·  AstraZeneca (1)  ·  Australian and New Zealand Intensive Care Research Centre (1)  ·  Azienda Sanitaria ASL Avellino 2 (1)  ·  Cerecin (1)  ·  Glasgow Royal Infirmary (1)  ·  Great Ormond Street Hospital for Children NHS Foundation Trust (1)  ·  Institute for Clinical and Experimental Medicine (1)  ·  Johns Hopkins University (1)  ·  Kantonsspital Baselland Bruderholz (1)  ·  POLYSAN Scientific & Technological Pharmaceutical Company (1)

Countries

United States (18)  ·  Australia (3)  ·  Bulgaria (3)  ·  Canada (3)  ·  Georgia (3)  ·  Hungary (3)  ·  Serbia (3)  ·  Ukraine (3)  ·  United Kingdom (3)  ·  Brazil (2)  ·  Czechia (2)  ·  France (2)  ·  Italy (2)  ·  Slovenia (2)  ·  Albania (1)

Top investigators

Corinde Wiers, Ph.D. (4)  ·  Thomas Hostetter, MD (2)  ·  Andre Ulmann, M.D., Ph.D. (1)  ·  Ary Serpa Neto, PhD (1)  ·  Biagio Di Iorio, MD, PhD (1)  ·  Corinde E Wiers, Ph.D. (1)  ·  Donogh Maguire, MB BCh (1)  ·  Eric H Kossoff, MD (1)  ·  Henry Kranzler, MD (1)  ·  Julio Montaner, MD (1)  ·  Kimberly Reidy, MD (1)  ·  Kyle Kampman, MD (1)  ·  Laurence Greenbaum, MD, Ph.D. (1)  ·  Mildred Farmer, MD (1)

Results publications

PMID 10102718, PMID 11046201, PMID 12243433, PMID 15115561, PMID 15591303, PMID 18666740, PMID 19115651, PMID 23393105, PMID 24415398, PMID 27770799, PMID 28606907, PMID 29866165, PMID 29910040, PMID 30857647, PMID 31248662, PMID 31598912, PMID 31699517, PMID 34009141, PMID 34784301, PMID 35216581, PMID 35484175, PMID 38261535, PMID 38622759, PMID 39665575, PMID 401925, PMID 40487345, PMID 42283370, PMID 8161863

NIH funding

R21AA031088 (2), 2016 (1), 2018 (1), 2023 (1), R01AA031570 (1), R01DK087783 (1), R01DK131811 (1), R21AA031337 (1), U01HD062417 (1)